VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HQH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HQHAbrdn Healthcare Investors
$22.09$1.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHQHQuarterly Financials

Abrdn Healthcare Investors (HQH) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Abrdn Healthcare Investors (HQH) quarterly income statement — complete revenue, gross profit & net income history

HQH Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17Q4'16Q2'16Q4'15Q2'15
Sales/Revenue--------------------
Revenue Growth %--------------------
Cost of Goods Sold--------------------
COGS % of Revenue--------------------
Gross Profit5.46M5.31M4.66M5.63M4.32M3.96M3.22M3.26M3.91M5.02M3.89M3.71M3.79M2.99M2.8M2.82M2.47M2.33M2.72M1.61M
Gross Margin %100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %17.15%-5.73%8.09%42.27%34.19%21.17%-17.8%-34.98%0.55%35.33%2.68%23.9%35.41%6.17%13.28%21.01%-9.31%45.01%133.02%64.87%
Operating Expenses5.65M5.34M5.69M5.79M5.75M6.19M6.55M6.16M5.69M5.22M5.15M5.32M5.46M5.45M5.6M5.18M5.29M5.8M6.43M5.75M
OpEx % of Revenue103.46%100.59%121.92%102.9%133.2%156.56%203.73%188.67%145.33%103.95%132.37%143.46%144.03%181.9%200.09%183.8%214.09%248.63%236.16%357.65%
Selling, General & Admin5.65M5.34M5.69M5.79M5.75M6.19M6.55M6.16M5.69M5.22M5.15M5.32M5.46M5.45M5.6M5.18M5.29M5.8M6.43M5.75M
SG&A % of Revenue103.46%100.59%121.92%102.9%133.2%156.56%203.73%188.67%145.33%103.95%132.37%143.46%144.03%181.9%200.09%183.8%214.09%248.63%236.16%357.65%
Research & Development--------------------
R&D % of Revenue--------------------
Other Operating Expenses--------------------
Operating Income-189.15K-31.12K-1.02M-163.15K-1.43M-2.24M-3.34M-2.89M-1.77M-198.43K-1.26M-1.61M-1.67M-2.45M-2.8M-2.36M-2.82M-3.46M-3.71M-4.14M
Operating Margin %-3.46%-0.59%-21.92%-2.9%-33.2%-56.56%-103.73%-88.67%-45.33%-3.95%-32.37%-43.46%-44.03%-81.9%-100.09%-83.8%-114.09%-148.63%-136.16%-257.65%
Operating Income Growth %81.5%80.92%28.65%92.71%57.04%22.71%-88.09%-1358.93%-40.81%87.69%24.52%34.25%40.43%-3.76%0.63%31.78%24.01%16.35%1.27%-21.8%
EBITDA00-100000000000000000
EBITDA Margin %--0%-----------------
EBITDA Growth %100%-------------------
D&A (Non-Cash Add-back)189.15K31.12K1.02M163.15K1.43M2.24M3.34M2.89M1.77M198.43K1.26M1.61M1.67M2.45M2.8M2.36M2.82M3.46M3.71M4.14M
EBIT-189.15K-31.12K-1.02M-163.15K-1.43M-2.24M-3.34M-2.89M-1.77M-198.43K-1.26M-1.61M-1.67M-2.45M-2.8M-2.36M-2.82M-3.46M-3.71M-4.14M
Net Interest Income00000000000000000000
Interest Income00000000000000000000
Interest Expense00000000000000000000
Other Income/Expense--------------------
Pretax Income85.25M99.7M-26.83M83.16M-79.18M-115.05M66.61M88.57M193.17M48.03M-60.9M-84.39M134.71M-65.51M85.58M35.7M62.48M-118.5M-108.97M205.13M
Pretax Margin %1560.21%1879.21%-575.22%1477.71%-1834.99%-2908.41%2071.36%2712.92%4938.03%956.56%-1565.27%-2274.64%3555.18%-2187.57%3058.12%1265.84%2529.25%-5083.7%-4000.14%12760.93%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income85.25M99.7M-26.83M83.16M-79.18M-115.05M66.61M88.57M193.17M48.03M-60.9M-84.39M134.71M-65.51M85.58M35.7M62.48M-118.5M-108.97M205.13M
Net Margin %1560.21%1879.21%-575.22%1477.71%-1834.99%-2908.41%2071.36%2712.92%4938.03%956.56%-1565.27%-2274.64%3555.18%-2187.57%3058.12%1265.84%2529.25%-5083.7%-4000.14%12760.93%
Net Income Growth %417.76%19.88%66.12%172.29%-218.88%-229.9%-65.52%84.4%417.19%156.91%-145.21%-28.83%57.42%-283.47%36.96%130.13%157.34%-157.77%-184.63%119.95%
Net Income (Continuing)85.25M99.7M-26.83M83.16M-79.18M-115.05M66.61M88.57M193.17M48.03M-60.9M-84.39M134.71M-65.51M85.58M35.7M62.48M-118.5M-108.97M205.13M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)1.591.97-0.531.72-1.64-2.481.441.984.331.11-1.41-1.993.14-1.582.060.901.57-3.10-2.865.62
EPS Growth %400%14.53%67.68%169.35%-213.89%-225.25%-66.74%78.38%407.09%155.78%-144.9%-25.95%52.43%-275.56%31.21%129.03%154.9%-155.16%-196.3%70.3%
EPS (Basic)1.591.97-0.531.72-1.64-2.481.441.984.331.11-1.41-1.993.14-1.582.060.901.57-3.10-2.865.62
Diluted Shares Outstanding53.63M50.62M50.53M48.35M48.34M46.34M46.2M44.65M44.66M43.08M43.31M42.34M42.88M41.55M41.44M39.86M39.81M38.19M38.11M36.49M
Basic Shares Outstanding53.63M50.62M50.53M48.35M48.34M46.34M46.2M44.65M44.66M43.08M43.31M42.34M42.88M41.55M41.44M39.86M39.81M38.19M38.11M36.49M
Dividend Payout Ratio19.68%------------------10.39%